Global Medicinal Mushroom Market Overview

Global Medicinal Mushroom Market Size Was Valued at USD 232.62 million In 2022 And Is Projected to Reach USD 436.98 million By 2030, Growing at A CAGR of 8.2% From 2023 To 2030.

Medicinal mushrooms are fungal organisms specifically basidiomycetes that are recognized as superfoods, nutritional supplements, and nutraceuticals. They form a part of the very extensive natural health products category in Asia where Traditional Chinese Medicine has utilized herbal preparations for thousands of years. In addition, Asia is also regarded as the historical site for mushroom cultivation. The cultivation of Shiitake, a medicinal mushroom has been reported to have originated in China in the 12th century and China produces 70% of the world's mushrooms. Eastern medicine practices have been utilizing medicinal mushrooms for thousands of years and have gained more popularity in recent times. Moreover, there are about 14,000 species of mushrooms worldwide, out of which 350 species are consumed around the globe.

Fungal species such as Lentinula edodes (Shiitake), Inonotus obliquus (Chaga), Ganoderma lingzhi or Ganoderma sichuanense (Lingzhi or Reishi), and many others have been collected in the wild and utilized as medicines for several hundred years in many Asian countries, such as Japan, China, and Korea. Such ancient traditional practices have stimulated modern scientific studies of fungal medicinal properties, especially anticancer bioactivities. Mushrooms are naturally taken in the form of powder. Medicinal mushrooms are also marketed in different forms such as dried slice, liquid, fresh, and capsules. The fresh fruiting bodies of these medicinal macrofungi have a moisture content of approximately 70–95%. The dry matter constitutes carbohydrates (50–65%), proteins (19–35%), and essential fatty acids (2–6%), with traces of vitamins and minerals. Thus, the rise in the consumption of mushrooms due to their medicinal properties is stimulating the expansion of the market in the forecast period.

Market Dynamics and Key Factors of Medicinal Mushroom Market

Drivers:

The rapidly increasing demand for medicinal mushrooms owing to their popularity among consumers, pleasant taste, and unique flavors is the main driving force for the expansion of the medicinal mushroom market over the projected period. Medicinal mushroom contains bioactive compounds such as high-quality proteins, polysaccharides, unsaturated fatty acids, minerals, triterpene sterols, and secondary metabolites thus, making them an important commodity for medicinal usage. Medicinal mushroom is popular for their ability to protect from or cure various health disorders, such as hypertension, immunodeficiency, cancer, inflammation, hypercholesterolemia, hyperlipidemia, and obesity. Several scientific studies have illustrated the medicinal properties of some mushrooms, supported by both in vivo and in vitro experimental studies, as well as clinical trials thus, promoting the expansion of the medicinal mushroom market during the period of forecast.

The converging trends and growing popularity of eastern herbal medicines, natural/organic and gut-healthy food products, and the growing inclination towards sports nutrition are vital components supporting the growth of the medicinal mushroom market. The consumption of medicinal mushrooms as functional food or dietary supplement is expected to rise in the coming years. Moreover, many studies have demonstrated that some sugars produced by mushrooms, such as rhamnose, mannose, fucose, mannitol, fructose, glucose, xylose, arabinose, sucrose, maltose, and trehalose, possess bioactivities. In addition, the antitumor activity of polysaccharides principally depends on the chemical structure. Many glycans present in mushrooms exhibit antitumor activities. These compounds activate the immune response of the host organisms thereby, indirectly targeting the tumor cells thus, there has been a significant increase in the consumption of mushrooms.

Certain medicinal mushrooms can be cooked, similar to regular culinary mushrooms. However, medicinal mushrooms are generally taken as extracts, which contain a higher concentration of beneficial active ingredients. Numerous bioactive compounds such as polysaccharides, proteins, fats, phenolic compounds, and vitamins, isolated from mushrooms possess strong bioactivities. Certain medicinal mushrooms can taste bitter and can be indigestible than regular mushrooms. Medicinal mushrooms are mostly dried, and then brewed into a tea or turned into high concentrated extracts making them an ideal drink thus, stimulating the development of the market during the forecast period.

Restraints:

The supply-demand gap is the main hampering factor for the growth of medicinal mushrooms in the forecast period. Moreover, the low shelf life of medicinal mushrooms and high pricing of mushroom-derived products may negatively impact the growth of the market. Furthermore, tiredness, stomach upset, dizziness, skin allergies, and headaches are some side effects faced by some individuals after consumption of medicinal mushrooms thus, hindering the development of the market during the forecast period.

Opportunities:

There has been a significant increase in the demand for medicinal mushrooms attributed to their health-promoting benefits thus, creating a profitable opportunity for market players to add mushroom extracts in different processed food products. There are 270 documented species of mushrooms as sources of important secondary metabolites, which can be utilized as food supplements. Even though only a handful of the 270 documented species of medicinal mushrooms are considered nutraceuticals. Many edible mushrooms are expected to get classified as nutraceuticals in the forecast period. Medicinal mushrooms have been traditionally utilized by different cultures throughout the world for the prevention and treatment of many diseases. The growing usage of mushroom extracts in processed foods such as bread, muffins, pasta, patties, and snacks are opening doors for market players in different food segments. In addition, several other processed food products containing mushroom extract have been manufactured, thus increasing the popularity of mushrooms among consumers. As a result, the awareness of the healthful benefits of incorporating mushrooms in the diet has increased. Certain medicinal properties of mushrooms such as antioxidant, antibacterial, antiviral, antiparasitic, antifungal, and anti-diabetic are gaining popularity among consumers thus, creating lucrative opportunities for the market players.

Challenges:

As more medicinal mushroom products are introduced in the market, systematic scientific verification of the active compounds will become an essential task to tackle counterfeit products. This has been applied to all medicinal herbs sold in the market as nutritional supplements, and is a vital factor of the regulatory framework that is so important to public health and safety. Verification of active compounds is also consistent with the need to keep the marketplace relatively free from products that are devoid of medicinal value, which can damage the credibility of the category.

Market Segmentation

Segmentation Analysis of Medicinal Mushroom Market

Depending on the form, the dried segment is forecasted to have the highest share of the medicinal mushroom market in the forecast period. Dried mushrooms are not manufactured for immediate consumption, but as an ingredient after rehydration. Moreover, they are widely utilized for household cooking, as an ingredient in dehydrated meals and spices, and as an ingredient in health food and pharmacy products. After rehydration (soaking in water for 30-60 minutes), they can be cooked in a similar way to fresh mushrooms. The characteristic of dried mushrooms is that the intensity of the taste and flavor increases after drying. Dried mushrooms, or powdered form of mushrooms, are most widely utilized for the production of food supplements than fresh mushrooms. Also, scientific studies have proven that sun-dried mushrooms provide more nutrients compared to fresh ones. For instance, a scientific study conducted on shiitake mushrooms indicates that 100g of fresh mushrooms, after having been placed in the sun for 12 hours, contained an additional 1000μg of vitamin D2.

Depending on the type, the Shiitake segment is forecasted to dominate the medicinal mushroom market. Shiitake mushrooms in the dried form are a great source of umami flavor. This mushroom can also be utilized as a meat substitute as it contains all the amino acids found in the meat thus, making it one of the healthiest mushrooms which can be consumed by individuals following a meat-free diet. Moreover, eritadenine, a compound found in shiitake mushrooms is known to reduce cholesterol levels in the blood. In addition, it also contains beta-glucans that help in reducing inflammation. Furthermore, lentinans and other beta-glucans found in shiitake protect against cell damage boost the immune system and white blood cell production to ward off microbes thus, supporting the growth of this segment in the forecast period.

Depending on the distribution channel, the supermarket and hypermarket segment is anticipated to lead the medicinal mushroom market in the forecast period. Supermarket and hypermarket stores offer a wide range of fresh mushrooms and mushroom-incorporated processed food products. Moreover, the discounts offered by these stores are attracting consumers thus, increasing the sales. The penetration of supermarkets and hypermarket stores is more in developed regions such as North America and Europe. Furthermore, buying mushrooms at supermarkets and hypermarket stores ensures the authenticity of the products thus, supporting the development of this segment in the forecast period.

Depending on end-users, the food and beverage industry segment is expected to develop at the highest growth rate in the projected period. The growing inclination toward ready-to-eat food products and the rising popularity of the beneficial properties of medicinal mushrooms are the essential factors driving the growth of the segments. Moreover, food and beverage companies are introducing new mushroom-based food and beverage products to meet the growing demand thus, driving the development of the food and beverage industry segment.

Regional Analysis of Medicinal Mushroom Market

The Asia-Pacific region is forecasted to dominate the medicinal mushroom market during the forecast period attributed to the growing inclination of consumers towards the benefits of medicinal mushrooms and an upsurge in the cultivation of mushrooms. Moreover, in this region, medicinal mushrooms have been utilized since ancient times. Furthermore, China is a prominent producer and a leading exporter of mushrooms all over the world. In addition, China has developed significant breeding and cultivation techniques of edible mushrooms, as well as product innovations, which has led to an increase in the production of mushrooms. The supportive government initiatives for the production of mushrooms are one of the vital components driving the expansion of the market in this region.

The European region is anticipated to have a significant growth rate over the projected period. The dried form is the most consumed form of mushroom in this region, attributed to the change in the consumption pattern of European consumers. Moreover, the rising interest in vegan food and animal protein replacement has increased the consumption of mushrooms in this region as it contains all the proteins found in meat. The economies such as Germany, Italy, France, the United Kingdom, the Netherlands, and Poland are the major contributors to the growth of the medicinal mushroom market in this region. Netherland is the major economy in Europe that has the highest import trade thus, supporting the medicinal market expansion in this region.

The North American region is expected to have a positive growth rate over the forecast period. The rise in the consumption of processed food items and growing awareness among consumers about the benefits of mushrooms are the primary factors driving the growth of the market in this region. The US, Canada, and Mexico are the major economies strengthening the development of the medicinal mushrooms market in this region. The growing consumer demand for vegan food products and the adoption of mushrooms in several food products are prominent factors further stimulating the expansion of the market in this region.

Top Key Players Covered in Medicinal Mushroom Market

• FreshCap Mushrooms LTD. (Canada)
• Banken Champignons B.V. (Netherlands)
• Far West Fungi (US)
• Swadeshi Mushroom (India)
• DXN (Malaysia)
• Nikkei Marketing Limited (Canada)
• Chaga Mountain Inc (US)
• Asia Pacific Farm Enterprises (Canada)
• NC Exotic Mushrooms (Netherlands)
• Bonduelle SA (France)
• Nammex (Canada)
• Naturalin (China)
• Real Mushrooms (Canada)
• Mitoku (Japan)
• Hirano Mushroom LLC (Serbia)
• Gourmet Mushrooms Inc. (US), and other major players.

COVID-19 Impact on Medicinal Mushroom Market

The surge in COVID-19 cases compelled several industries to shut down. Moreover, working in agricultural fields was also restricted to a limited number of individuals. To curb the spread of the virus several economies declared lockdowns. In South Asian countries such as India, Bangladesh, and Sri Lanka migrant workers started returning homes which affected the production of mushrooms. Furthermore, in the last few years mushroom cultivation in India has been gaining momentum. It has been reported that India produced 17,100 metric tonnes of mushroom in 2013-14, which increased to 4,87,000 MT by 2018. The disruption in the supply chain worldwide created a huge demand-supply gap and restricted access to markets, thus increasing the prices of food commodities which negatively impacted the consumption pattern. Furthermore, the COVID-19 pandemic has stimulated the cultivation practice of mushrooms as this fungal organism is easy to cultivate and gives a good return. Many workers from several parts of the world started the cultivation of medicinal mushrooms to meet their day-to-day needs. For instance, workers from India are promoted by the Indian government under the program Seva Kendra Silchar to produce nutrient-rich crops, this helped the farmers to cultivate mushrooms in their farms and cope with the ongoing pandemic crisis. During the pandemic period, the consumption of mushrooms has significantly increased owing to the rising inclination of consumers towards the immune-boosting property of mushrooms. To summarize, the COVID-19 pandemic has boosted the cultivation of medicinal mushrooms attributed to their various bioactivities.

Key Industry Development In Medicinal Mushroom Market

• In February 2021, FreshCap Mushrooms LTD., a global leading manufacturer of mushroom-derived nutrition products, declared the launch of three new functional mushroom beverage products. Mushroom Coffee, Focus Lion's Mane Elixir, and Unwind Reishi Elixir are the new launches products. These new products are manufactured to offer individuals with refreshing drinks in their leisure time.

Chapter 1: Introduction
 1.1 Research Objectives
 1.2 Research Methodology
 1.3 Research Process
 1.4 Scope and Coverage
  1.4.1 Market Definition
  1.4.2 Key Questions Answered
 1.5 Market Segmentation

Chapter 2:Executive Summary

Chapter 3:Growth Opportunities By Segment
 3.1 By Type
 3.2 By Distribution Channel
 3.3 By Form
 3.4 By End User

Chapter 4: Market Landscape
 4.1 Porter's Five Forces Analysis
  4.1.1 Bargaining Power of Supplier
  4.1.2 Threat of New Entrants
  4.1.3 Threat of Substitutes
  4.1.4 Competitive Rivalry
  4.1.5 Bargaining Power Among Buyers
 4.2 Industry Value Chain Analysis
 4.3 Market Dynamics
  4.3.1 Drivers
  4.3.2 Restraints
  4.3.3 Opportunities
  4.5.4 Challenges
 4.4 Pestle Analysis
 4.5 Technological Roadmap
 4.6 Regulatory Landscape
 4.7 SWOT Analysis
 4.8 Price Trend Analysis
 4.9 Patent Analysis
 4.10 Analysis of the Impact of Covid-19
  4.10.1 Impact on the Overall Market
  4.10.2 Impact on the Supply Chain
  4.10.3 Impact on the Key Manufacturers
  4.10.4 Impact on the Pricing

Chapter 5: Medicinal Mushroom Market by Type
 5.1 Medicinal Mushroom Market Overview Snapshot and Growth Engine
 5.2 Medicinal Mushroom Market Overview
 5.3 Shiitake
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size (2016-2028F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Shiitake: Grographic Segmentation
 5.4 Cordyceps
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size (2016-2028F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Cordyceps: Grographic Segmentation
 5.5 Turkey Tail
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size (2016-2028F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Turkey Tail: Grographic Segmentation
 5.6 Chaga
  5.6.1 Introduction and Market Overview
  5.6.2 Historic and Forecasted Market Size (2016-2028F)
  5.6.3 Key Market Trends, Growth Factors and Opportunities
  5.6.4 Chaga: Grographic Segmentation
 5.7 Others
  5.7.1 Introduction and Market Overview
  5.7.2 Historic and Forecasted Market Size (2016-2028F)
  5.7.3 Key Market Trends, Growth Factors and Opportunities
  5.7.4 Others: Grographic Segmentation

Chapter 6: Medicinal Mushroom Market by Distribution Channel
 6.1 Medicinal Mushroom Market Overview Snapshot and Growth Engine
 6.2 Medicinal Mushroom Market Overview
 6.3 Supermarkets/Hypermarkets
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size (2016-2028F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Supermarkets/Hypermarkets: Grographic Segmentation
 6.4 Convenience Stores
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size (2016-2028F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Convenience Stores: Grographic Segmentation
 6.5 E-Commerce
  6.5.1 Introduction and Market Overview
  6.5.2 Historic and Forecasted Market Size (2016-2028F)
  6.5.3 Key Market Trends, Growth Factors and Opportunities
  6.5.4 E-Commerce: Grographic Segmentation

Chapter 7: Medicinal Mushroom Market by Form
 7.1 Medicinal Mushroom Market Overview Snapshot and Growth Engine
 7.2 Medicinal Mushroom Market Overview
 7.3 Whole
  7.3.1 Introduction and Market Overview
  7.3.2 Historic and Forecasted Market Size (2016-2028F)
  7.3.3 Key Market Trends, Growth Factors and Opportunities
  7.3.4 Whole: Grographic Segmentation
 7.4 Dried
  7.4.1 Introduction and Market Overview
  7.4.2 Historic and Forecasted Market Size (2016-2028F)
  7.4.3 Key Market Trends, Growth Factors and Opportunities
  7.4.4 Dried: Grographic Segmentation
 7.5 Liquid
  7.5.1 Introduction and Market Overview
  7.5.2 Historic and Forecasted Market Size (2016-2028F)
  7.5.3 Key Market Trends, Growth Factors and Opportunities
  7.5.4 Liquid: Grographic Segmentation
 7.6 Capsules
  7.6.1 Introduction and Market Overview
  7.6.2 Historic and Forecasted Market Size (2016-2028F)
  7.6.3 Key Market Trends, Growth Factors and Opportunities
  7.6.4 Capsules: Grographic Segmentation

Chapter 8: Medicinal Mushroom Market by End User
 8.1 Medicinal Mushroom Market Overview Snapshot and Growth Engine
 8.2 Medicinal Mushroom Market Overview
 8.3 Food & Beverage Industry
  8.3.1 Introduction and Market Overview
  8.3.2 Historic and Forecasted Market Size (2016-2028F)
  8.3.3 Key Market Trends, Growth Factors and Opportunities
  8.3.4 Food & Beverage Industry: Grographic Segmentation
 8.4 Pharmaceutical Industry
  8.4.1 Introduction and Market Overview
  8.4.2 Historic and Forecasted Market Size (2016-2028F)
  8.4.3 Key Market Trends, Growth Factors and Opportunities
  8.4.4 Pharmaceutical Industry: Grographic Segmentation

Chapter 9: Company Profiles and Competitive Analysis
 9.1 Competitive Landscape
  9.1.1 Competitive Positioning
  9.1.2 Medicinal Mushroom Sales and Market Share By Players
  9.1.3 Industry BCG Matrix
  9.1.4 Ansoff Matrix
  9.1.5 Medicinal Mushroom Industry Concentration Ratio (CR5 and HHI)
  9.1.6 Top 5 Medicinal Mushroom Players Market Share
  9.1.7 Mergers and Acquisitions
  9.1.8 Business Strategies By Top Players
 9.2 FRESHCAP MUSHROOMS LTD.
  9.2.1 Company Overview
  9.2.2 Key Executives
  9.2.3 Company Snapshot
  9.2.4 Operating Business Segments
  9.2.5 Product Portfolio
  9.2.6 Business Performance
  9.2.7 Key Strategic Moves and Recent Developments
  9.2.8 SWOT Analysis
 9.3 BANKEN CHAMPIGNONS B.V.
 9.4 FAR WEST FUNGI
 9.5 SWADESHI MUSHROOM
 9.6 DXN
 9.7 NIKKEI MARKETING LIMITED
 9.8 CHAGA MOUNTAIN INC
 9.9 ASIA PACIFIC FARM ENTERPRISES
 9.10 NC EXOTIC MUSHROOMS
 9.11 BONDUELLE SA
 9.12 NAMMEX
 9.13 NATURALIN
 9.14 REAL MUSHROOMS
 9.15 MITOKU
 9.16 HIRANO MUSHROOM LLC
 9.17 GOURMET MUSHROOMS INC.
 9.18 OTHER MAJOR PLAYERS

Chapter 10: Global Medicinal Mushroom Market Analysis, Insights and Forecast, 2016-2028
 10.1 Market Overview
 10.2 Historic and Forecasted Market Size By Type
  10.2.1 Shiitake
  10.2.2 Cordyceps
  10.2.3 Turkey Tail
  10.2.4 Chaga
  10.2.5 Others
 10.3 Historic and Forecasted Market Size By Distribution Channel
  10.3.1 Supermarkets/Hypermarkets
  10.3.2 Convenience Stores
  10.3.3 E-Commerce
 10.4 Historic and Forecasted Market Size By Form
  10.4.1 Whole
  10.4.2 Dried
  10.4.3 Liquid
  10.4.4 Capsules
 10.5 Historic and Forecasted Market Size By End User
  10.5.1 Food & Beverage Industry
  10.5.2 Pharmaceutical Industry

Chapter 11: North America Medicinal Mushroom Market Analysis, Insights and Forecast, 2016-2028
 11.1 Key Market Trends, Growth Factors and Opportunities
 11.2 Impact of Covid-19
 11.3 Key Players
 11.4 Key Market Trends, Growth Factors and Opportunities
 11.4 Historic and Forecasted Market Size By Type
  11.4.1 Shiitake
  11.4.2 Cordyceps
  11.4.3 Turkey Tail
  11.4.4 Chaga
  11.4.5 Others
 11.5 Historic and Forecasted Market Size By Distribution Channel
  11.5.1 Supermarkets/Hypermarkets
  11.5.2 Convenience Stores
  11.5.3 E-Commerce
 11.6 Historic and Forecasted Market Size By Form
  11.6.1 Whole
  11.6.2 Dried
  11.6.3 Liquid
  11.6.4 Capsules
 11.7 Historic and Forecasted Market Size By End User
  11.7.1 Food & Beverage Industry
  11.7.2 Pharmaceutical Industry
 11.8 Historic and Forecast Market Size by Country
  11.8.1 U.S.
  11.8.2 Canada
  11.8.3 Mexico

Chapter 12: Europe Medicinal Mushroom Market Analysis, Insights and Forecast, 2016-2028
 12.1 Key Market Trends, Growth Factors and Opportunities
 12.2 Impact of Covid-19
 12.3 Key Players
 12.4 Key Market Trends, Growth Factors and Opportunities
 12.4 Historic and Forecasted Market Size By Type
  12.4.1 Shiitake
  12.4.2 Cordyceps
  12.4.3 Turkey Tail
  12.4.4 Chaga
  12.4.5 Others
 12.5 Historic and Forecasted Market Size By Distribution Channel
  12.5.1 Supermarkets/Hypermarkets
  12.5.2 Convenience Stores
  12.5.3 E-Commerce
 12.6 Historic and Forecasted Market Size By Form
  12.6.1 Whole
  12.6.2 Dried
  12.6.3 Liquid
  12.6.4 Capsules
 12.7 Historic and Forecasted Market Size By End User
  12.7.1 Food & Beverage Industry
  12.7.2 Pharmaceutical Industry
 12.8 Historic and Forecast Market Size by Country
  12.8.1 Germany
  12.8.2 U.K.
  12.8.3 France
  12.8.4 Italy
  12.8.5 Russia
  12.8.6 Spain
  12.8.7 Rest of Europe

Chapter 13: Asia-Pacific Medicinal Mushroom Market Analysis, Insights and Forecast, 2016-2028
 13.1 Key Market Trends, Growth Factors and Opportunities
 13.2 Impact of Covid-19
 13.3 Key Players
 13.4 Key Market Trends, Growth Factors and Opportunities
 13.4 Historic and Forecasted Market Size By Type
  13.4.1 Shiitake
  13.4.2 Cordyceps
  13.4.3 Turkey Tail
  13.4.4 Chaga
  13.4.5 Others
 13.5 Historic and Forecasted Market Size By Distribution Channel
  13.5.1 Supermarkets/Hypermarkets
  13.5.2 Convenience Stores
  13.5.3 E-Commerce
 13.6 Historic and Forecasted Market Size By Form
  13.6.1 Whole
  13.6.2 Dried
  13.6.3 Liquid
  13.6.4 Capsules
 13.7 Historic and Forecasted Market Size By End User
  13.7.1 Food & Beverage Industry
  13.7.2 Pharmaceutical Industry
 13.8 Historic and Forecast Market Size by Country
  13.8.1 China
  13.8.2 India
  13.8.3 Japan
  13.8.4 Singapore
  13.8.5 Australia
  13.8.6 New Zealand
  13.8.7 Rest of APAC

Chapter 14: Middle East & Africa Medicinal Mushroom Market Analysis, Insights and Forecast, 2016-2028
 14.1 Key Market Trends, Growth Factors and Opportunities
 14.2 Impact of Covid-19
 14.3 Key Players
 14.4 Key Market Trends, Growth Factors and Opportunities
 14.4 Historic and Forecasted Market Size By Type
  14.4.1 Shiitake
  14.4.2 Cordyceps
  14.4.3 Turkey Tail
  14.4.4 Chaga
  14.4.5 Others
 14.5 Historic and Forecasted Market Size By Distribution Channel
  14.5.1 Supermarkets/Hypermarkets
  14.5.2 Convenience Stores
  14.5.3 E-Commerce
 14.6 Historic and Forecasted Market Size By Form
  14.6.1 Whole
  14.6.2 Dried
  14.6.3 Liquid
  14.6.4 Capsules
 14.7 Historic and Forecasted Market Size By End User
  14.7.1 Food & Beverage Industry
  14.7.2 Pharmaceutical Industry
 14.8 Historic and Forecast Market Size by Country
  14.8.1 Turkey
  14.8.2 Saudi Arabia
  14.8.3 Iran
  14.8.4 UAE
  14.8.5 Africa
  14.8.6 Rest of MEA

Chapter 15: South America Medicinal Mushroom Market Analysis, Insights and Forecast, 2016-2028
 15.1 Key Market Trends, Growth Factors and Opportunities
 15.2 Impact of Covid-19
 15.3 Key Players
 15.4 Key Market Trends, Growth Factors and Opportunities
 15.4 Historic and Forecasted Market Size By Type
  15.4.1 Shiitake
  15.4.2 Cordyceps
  15.4.3 Turkey Tail
  15.4.4 Chaga
  15.4.5 Others
 15.5 Historic and Forecasted Market Size By Distribution Channel
  15.5.1 Supermarkets/Hypermarkets
  15.5.2 Convenience Stores
  15.5.3 E-Commerce
 15.6 Historic and Forecasted Market Size By Form
  15.6.1 Whole
  15.6.2 Dried
  15.6.3 Liquid
  15.6.4 Capsules
 15.7 Historic and Forecasted Market Size By End User
  15.7.1 Food & Beverage Industry
  15.7.2 Pharmaceutical Industry
 15.8 Historic and Forecast Market Size by Country
  15.8.1 Brazil
  15.8.2 Argentina
  15.8.3 Rest of SA

Chapter 16 Investment Analysis

Chapter 17 Analyst Viewpoint and Conclusion

LIST OF TABLES

TABLE 001. EXECUTIVE SUMMARY
TABLE 002. MEDICINAL MUSHROOM MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. MEDICINAL MUSHROOM MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. MEDICINAL MUSHROOM MARKET COMPETITIVE RIVALRY
TABLE 005. MEDICINAL MUSHROOM MARKET THREAT OF NEW ENTRANTS
TABLE 006. MEDICINAL MUSHROOM MARKET THREAT OF SUBSTITUTES
TABLE 007. MEDICINAL MUSHROOM MARKET BY TYPE
TABLE 008. SHIITAKE MARKET OVERVIEW (2016-2028)
TABLE 009. CORDYCEPS MARKET OVERVIEW (2016-2028)
TABLE 010. TURKEY TAIL MARKET OVERVIEW (2016-2028)
TABLE 011. CHAGA MARKET OVERVIEW (2016-2028)
TABLE 012. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 013. MEDICINAL MUSHROOM MARKET BY DISTRIBUTION CHANNEL
TABLE 014. SUPERMARKETS/HYPERMARKETS MARKET OVERVIEW (2016-2028)
TABLE 015. CONVENIENCE STORES MARKET OVERVIEW (2016-2028)
TABLE 016. E-COMMERCE MARKET OVERVIEW (2016-2028)
TABLE 017. MEDICINAL MUSHROOM MARKET BY FORM
TABLE 018. WHOLE MARKET OVERVIEW (2016-2028)
TABLE 019. DRIED MARKET OVERVIEW (2016-2028)
TABLE 020. LIQUID MARKET OVERVIEW (2016-2028)
TABLE 021. CAPSULES MARKET OVERVIEW (2016-2028)
TABLE 022. MEDICINAL MUSHROOM MARKET BY END USER
TABLE 023. FOOD & BEVERAGE INDUSTRY MARKET OVERVIEW (2016-2028)
TABLE 024. PHARMACEUTICAL INDUSTRY MARKET OVERVIEW (2016-2028)
TABLE 025. NORTH AMERICA MEDICINAL MUSHROOM MARKET, BY TYPE (2016-2028)
TABLE 026. NORTH AMERICA MEDICINAL MUSHROOM MARKET, BY DISTRIBUTION CHANNEL (2016-2028)
TABLE 027. NORTH AMERICA MEDICINAL MUSHROOM MARKET, BY FORM (2016-2028)
TABLE 028. NORTH AMERICA MEDICINAL MUSHROOM MARKET, BY END USER (2016-2028)
TABLE 029. N MEDICINAL MUSHROOM MARKET, BY COUNTRY (2016-2028)
TABLE 030. EUROPE MEDICINAL MUSHROOM MARKET, BY TYPE (2016-2028)
TABLE 031. EUROPE MEDICINAL MUSHROOM MARKET, BY DISTRIBUTION CHANNEL (2016-2028)
TABLE 032. EUROPE MEDICINAL MUSHROOM MARKET, BY FORM (2016-2028)
TABLE 033. EUROPE MEDICINAL MUSHROOM MARKET, BY END USER (2016-2028)
TABLE 034. MEDICINAL MUSHROOM MARKET, BY COUNTRY (2016-2028)
TABLE 035. ASIA PACIFIC MEDICINAL MUSHROOM MARKET, BY TYPE (2016-2028)
TABLE 036. ASIA PACIFIC MEDICINAL MUSHROOM MARKET, BY DISTRIBUTION CHANNEL (2016-2028)
TABLE 037. ASIA PACIFIC MEDICINAL MUSHROOM MARKET, BY FORM (2016-2028)
TABLE 038. ASIA PACIFIC MEDICINAL MUSHROOM MARKET, BY END USER (2016-2028)
TABLE 039. MEDICINAL MUSHROOM MARKET, BY COUNTRY (2016-2028)
TABLE 040. MIDDLE EAST & AFRICA MEDICINAL MUSHROOM MARKET, BY TYPE (2016-2028)
TABLE 041. MIDDLE EAST & AFRICA MEDICINAL MUSHROOM MARKET, BY DISTRIBUTION CHANNEL (2016-2028)
TABLE 042. MIDDLE EAST & AFRICA MEDICINAL MUSHROOM MARKET, BY FORM (2016-2028)
TABLE 043. MIDDLE EAST & AFRICA MEDICINAL MUSHROOM MARKET, BY END USER (2016-2028)
TABLE 044. MEDICINAL MUSHROOM MARKET, BY COUNTRY (2016-2028)
TABLE 045. SOUTH AMERICA MEDICINAL MUSHROOM MARKET, BY TYPE (2016-2028)
TABLE 046. SOUTH AMERICA MEDICINAL MUSHROOM MARKET, BY DISTRIBUTION CHANNEL (2016-2028)
TABLE 047. SOUTH AMERICA MEDICINAL MUSHROOM MARKET, BY FORM (2016-2028)
TABLE 048. SOUTH AMERICA MEDICINAL MUSHROOM MARKET, BY END USER (2016-2028)
TABLE 049. MEDICINAL MUSHROOM MARKET, BY COUNTRY (2016-2028)
TABLE 050. FRESHCAP MUSHROOMS LTD.: SNAPSHOT
TABLE 051. FRESHCAP MUSHROOMS LTD.: BUSINESS PERFORMANCE
TABLE 052. FRESHCAP MUSHROOMS LTD.: PRODUCT PORTFOLIO
TABLE 053. FRESHCAP MUSHROOMS LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 053. BANKEN CHAMPIGNONS B.V.: SNAPSHOT
TABLE 054. BANKEN CHAMPIGNONS B.V.: BUSINESS PERFORMANCE
TABLE 055. BANKEN CHAMPIGNONS B.V.: PRODUCT PORTFOLIO
TABLE 056. BANKEN CHAMPIGNONS B.V.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 056. FAR WEST FUNGI: SNAPSHOT
TABLE 057. FAR WEST FUNGI: BUSINESS PERFORMANCE
TABLE 058. FAR WEST FUNGI: PRODUCT PORTFOLIO
TABLE 059. FAR WEST FUNGI: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 059. SWADESHI MUSHROOM: SNAPSHOT
TABLE 060. SWADESHI MUSHROOM: BUSINESS PERFORMANCE
TABLE 061. SWADESHI MUSHROOM: PRODUCT PORTFOLIO
TABLE 062. SWADESHI MUSHROOM: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 062. DXN: SNAPSHOT
TABLE 063. DXN: BUSINESS PERFORMANCE
TABLE 064. DXN: PRODUCT PORTFOLIO
TABLE 065. DXN: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 065. NIKKEI MARKETING LIMITED: SNAPSHOT
TABLE 066. NIKKEI MARKETING LIMITED: BUSINESS PERFORMANCE
TABLE 067. NIKKEI MARKETING LIMITED: PRODUCT PORTFOLIO
TABLE 068. NIKKEI MARKETING LIMITED: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 068. CHAGA MOUNTAIN INC: SNAPSHOT
TABLE 069. CHAGA MOUNTAIN INC: BUSINESS PERFORMANCE
TABLE 070. CHAGA MOUNTAIN INC: PRODUCT PORTFOLIO
TABLE 071. CHAGA MOUNTAIN INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 071. ASIA PACIFIC FARM ENTERPRISES: SNAPSHOT
TABLE 072. ASIA PACIFIC FARM ENTERPRISES: BUSINESS PERFORMANCE
TABLE 073. ASIA PACIFIC FARM ENTERPRISES: PRODUCT PORTFOLIO
TABLE 074. ASIA PACIFIC FARM ENTERPRISES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 074. NC EXOTIC MUSHROOMS: SNAPSHOT
TABLE 075. NC EXOTIC MUSHROOMS: BUSINESS PERFORMANCE
TABLE 076. NC EXOTIC MUSHROOMS: PRODUCT PORTFOLIO
TABLE 077. NC EXOTIC MUSHROOMS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 077. BONDUELLE SA: SNAPSHOT
TABLE 078. BONDUELLE SA: BUSINESS PERFORMANCE
TABLE 079. BONDUELLE SA: PRODUCT PORTFOLIO
TABLE 080. BONDUELLE SA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 080. NAMMEX: SNAPSHOT
TABLE 081. NAMMEX: BUSINESS PERFORMANCE
TABLE 082. NAMMEX: PRODUCT PORTFOLIO
TABLE 083. NAMMEX: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 083. NATURALIN: SNAPSHOT
TABLE 084. NATURALIN: BUSINESS PERFORMANCE
TABLE 085. NATURALIN: PRODUCT PORTFOLIO
TABLE 086. NATURALIN: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 086. REAL MUSHROOMS: SNAPSHOT
TABLE 087. REAL MUSHROOMS: BUSINESS PERFORMANCE
TABLE 088. REAL MUSHROOMS: PRODUCT PORTFOLIO
TABLE 089. REAL MUSHROOMS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 089. MITOKU: SNAPSHOT
TABLE 090. MITOKU: BUSINESS PERFORMANCE
TABLE 091. MITOKU: PRODUCT PORTFOLIO
TABLE 092. MITOKU: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 092. HIRANO MUSHROOM LLC: SNAPSHOT
TABLE 093. HIRANO MUSHROOM LLC: BUSINESS PERFORMANCE
TABLE 094. HIRANO MUSHROOM LLC: PRODUCT PORTFOLIO
TABLE 095. HIRANO MUSHROOM LLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 095. GOURMET MUSHROOMS INC.: SNAPSHOT
TABLE 096. GOURMET MUSHROOMS INC.: BUSINESS PERFORMANCE
TABLE 097. GOURMET MUSHROOMS INC.: PRODUCT PORTFOLIO
TABLE 098. GOURMET MUSHROOMS INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 098. OTHER MAJOR PLAYERS: SNAPSHOT
TABLE 099. OTHER MAJOR PLAYERS: BUSINESS PERFORMANCE
TABLE 100. OTHER MAJOR PLAYERS: PRODUCT PORTFOLIO
TABLE 101. OTHER MAJOR PLAYERS: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. MEDICINAL MUSHROOM MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. MEDICINAL MUSHROOM MARKET OVERVIEW BY TYPE
FIGURE 012. SHIITAKE MARKET OVERVIEW (2016-2028)
FIGURE 013. CORDYCEPS MARKET OVERVIEW (2016-2028)
FIGURE 014. TURKEY TAIL MARKET OVERVIEW (2016-2028)
FIGURE 015. CHAGA MARKET OVERVIEW (2016-2028)
FIGURE 016. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 017. MEDICINAL MUSHROOM MARKET OVERVIEW BY DISTRIBUTION CHANNEL
FIGURE 018. SUPERMARKETS/HYPERMARKETS MARKET OVERVIEW (2016-2028)
FIGURE 019. CONVENIENCE STORES MARKET OVERVIEW (2016-2028)
FIGURE 020. E-COMMERCE MARKET OVERVIEW (2016-2028)
FIGURE 021. MEDICINAL MUSHROOM MARKET OVERVIEW BY FORM
FIGURE 022. WHOLE MARKET OVERVIEW (2016-2028)
FIGURE 023. DRIED MARKET OVERVIEW (2016-2028)
FIGURE 024. LIQUID MARKET OVERVIEW (2016-2028)
FIGURE 025. CAPSULES MARKET OVERVIEW (2016-2028)
FIGURE 026. MEDICINAL MUSHROOM MARKET OVERVIEW BY END USER
FIGURE 027. FOOD & BEVERAGE INDUSTRY MARKET OVERVIEW (2016-2028)
FIGURE 028. PHARMACEUTICAL INDUSTRY MARKET OVERVIEW (2016-2028)
FIGURE 029. NORTH AMERICA MEDICINAL MUSHROOM MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 030. EUROPE MEDICINAL MUSHROOM MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 031. ASIA PACIFIC MEDICINAL MUSHROOM MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 032. MIDDLE EAST & AFRICA MEDICINAL MUSHROOM MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 033. SOUTH AMERICA MEDICINAL MUSHROOM MARKET OVERVIEW BY COUNTRY (2016-2028)